ACP
Acuta Capital Partners Portfolio holdings
AUM
$71.6M
This Quarter Return
+11.39%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$188M
AUM Growth
+$188M
(+19%)
Cap. Flow
+$34.4M
Cap. Flow
% of AUM
18.33%
Top 10 Holdings %
Top 10 Hldgs %
58.06%
Holding
79
New
17
Increased
16
Reduced
10
Closed
22
Top Buys
| 1 |
Universal Display
OLED
|
$15.6M |
| 2 |
CEMP
Cempra, Inc.
CEMP
|
$7.32M |
| 3 |
Travere Therapeutics
TVTX
|
$7.14M |
| 4 |
IMMU
Immunomedics Inc
IMMU
|
$6.92M |
| 5 |
SBBP
Strongbridge Biopharma plc.
SBBP
|
$6.87M |
Top Sells
| 1 |
Lexicon Pharmaceuticals
LXRX
|
$4.3M |
| 2 |
Exelixis
EXEL
|
$3.79M |
| 3 |
BEAT
BioTelemetry, Inc.
BEAT
|
$3.5M |
| 4 |
WBMD
WebMD Health Corp.
WBMD
|
$3.18M |
| 5 |
BioCryst Pharmaceuticals
BCRX
|
$3.09M |
Sector Composition
| 1 | Healthcare | 73.71% |
| 2 | Technology | 8.34% |
| 3 | Consumer Discretionary | 1.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Universal Display
OLED
$6.59B
| $15.6M | 7.48% | +287,397 | New | +$15.6M |
|
2
Iovance Biotherapeutics
IOVA
$807M
| $14.8M | 7.07% | 1,915,000 +600,041 | +46% | +$4.63M |
|
3
Amicus Therapeutics
FOLD
$2.34B
| $14.6M | 6.97% | 1,502,661 +97,994 | +7% | +$951K |
|
4
Veracyte
VCYT
$2.39B
| $12.4M | 5.91% | 1,716,000 +811,000 | +90% | +$5.84M |
|
|
IMMU
5
DELISTED
Immunomedics Inc
IMMU
| $12.2M | 5.82% | 3,964,033 +2,252,966 | +132% | +$6.92M |
|
6
Ascendis Pharma
ASND
$11.8B
| $9.51M | 4.55% | 519,243 +49,350 | +11% | +$904K |
|
|
NDRM
7
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $8.14M | 3.89% | 477,300 -19,330 | -4% | -$330K |
|
|
CEMP
8
DELISTED
Cempra, Inc.
CEMP
| $7.78M | 3.72% | 250,000 +235,000 | +1,567% | +$7.32M |
|
|
9
Travere Therapeutics
TVTX
$1.56B
| $7.14M | 3.41% | +370,000 | New | +$7.14M |
|
|
SBBP
10
DELISTED
Strongbridge Biopharma plc.
SBBP
| $6.87M | 3.28% | +978,907 | New | +$6.87M |
|
|
11
Exelixis
EXEL
$10.1B
| $6.81M | 3.26% | 1,207,726 -672,278 | -36% | -$3.79M |
|
|
CYNA
12
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
| $5.76M | 2.75% | 376,647 +63,123 | +20% | +$965K |
|
13
Incyte
INCY
$16.5B
| $4.78M | 2.29% | +44,078 | New | +$4.78M |
|
|
CASM
14
DELISTED
CAS Medical Systems, Inc.
CASM
| $4.52M | 2.16% | 2,551,803 +4,504 | +0.2% | +$7.97K |
|
|
RRM
15
DELISTED
RR MEDIA LTD ORD SHS (ISR)
RRM
| $4.5M | 2.15% | 497,227 +27,877 | +6% | +$252K |
|
16
IRIDEX
IRIX
$22.8M
| $4.25M | 2.03% | 457,000 +59,804 | +15% | +$556K |
|
|
NBRV
17
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $3.97M | 1.9% | 412,747 +61,486 | +18% | +$592K |
|
18
Neurocrine Biosciences
NBIX
$13.8B
| $3.17M | 1.52% | +56,000 | New | +$3.17M |
|
|
MRTX
19
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $2.8M | 1.34% | +88,439 | New | +$2.8M |
|
|
INNL
20
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
| $2.66M | 1.27% | 320,555 +46,574 | +17% | +$387K |
|
21
Atara Biotherapeutics
ATRA
$84.6M
| $2.51M | 1.2% | +95,000 | New | +$2.51M |
|
|
ALIM
22
DELISTED
Alimera Sciences, Inc.
ALIM
| $2.36M | 1.13% | 974,318 | – | – |
|
|
SGNT
23
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $2.3M | 1.1% | 144,667 -37,951 | -21% | -$604K |
|
|
LJPC
24
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $2.24M | 1.07% | 82,920 -39,302 | -32% | -$1.06M |
|
|
OXFD
25
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $2.19M | 1.05% | 190,100 +5,354 | +3% | +$61.6K |
|